1-5 of 5
Carrie Turich Taylor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS Trial

Open Access
Clinical Trials & Observations
Davide Matino, Andrew Palladino, Carrie Turich Taylor, Eunhee Hwang, Sangeeta Raje, Satyaprakash Nayak, Regina McDonald, Suchitra Acharya, Johnny Mahlangu, Victor Jiménez-Yuste, Nirmalkumar G Choraria, Dr., Renchi Yang, Chi-kong Li, Murtadha Al-Khabori, Yasser Ahmed Mohamed Soliman Wali, Javier De Jesus Morales-Adrian, Young-Shil Park, Osman Bülent Zülfikar, John Teeter
Journal: Blood
Blood blood.2024027468.
https://doi.org/10.1182/blood.2024027468
Published: 2025
Includes: Supplemental data
Journal Articles

Safety Biomarkers in Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B Without Inhibitors Receiving Prophylactic Marstacimab Treatment: Results From the Phase 3 BASIS Trial

Free
Carrie Turich Taylor, Eunhee Hwang, Tina Hinnershitz, Eugeny Mefyod, Sangeeta V Raje, John Teeter, Travis Gould, Andrew Palladino
Journal: Blood
Blood (2024) 144 (Supplement 1): 1210.
https://doi.org/10.1182/blood-2024-205843
Published: 2024
Journal Articles

Descriptive Characterization of Bleeding Events in Participants with Severe Hemophilia Α or B without Inhibitors, Receiving Prophylactic Marstacimab Treatment

Free
Davide Matino, Travis Gould, John Teeter, Carrie Turich Taylor, Regina McDonald, Andrew Palladino
Journal: Blood
Blood (2024) 144 (Supplement 1): 716.
https://doi.org/10.1182/blood-2024-205975
Published: 2024
Journal Articles

Efficacy and Safety of the Anti-Tissue Factor Pathway Inhibitor Marstacimab in Participants with Severe Hemophilia without Inhibitors: Results from the Phase 3 Basis Trial

Free
Davide Matino, Suchitra Acharya, Andrew Palladino, Eunhee Hwang, Regina McDonald, Carrie Turich Taylor, John Teeter
Journal: Blood
Blood (2023) 142 (Supplement 1): 285.
https://doi.org/10.1182/blood-2023-181263
Published: 2023
Journal Articles

Marstacimab, an Anti-Tissue Factor Pathway Inhibitor, in Participants with Hemophilia Α or B, with and without Inhibitors: An Integrated Analysis of Safety

Free
Suchitra Acharya, Davide Matino, Johnny Mahlangu, Carrie Turich Taylor, Eunhee Hwang, Tina Hinnershitz, Eugeny Mefyod, Andrew Palladino, Francesca Biondo, Travis Gould, John Teeter
Journal: Blood
Blood (2023) 142 (Supplement 1): 3980.
https://doi.org/10.1182/blood-2023-174682
Published: 2023